| The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen AK Jain, NK Swarnakar, C Godugu, RP Singh, S Jain Biomaterials 32 (2), 503-515, 2011 | 255 | 2011 |
| Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel S Jain, D Kumar, NK Swarnakar, K Thanki Biomaterials 33 (28), 6758-6768, 2012 | 205 | 2012 |
| Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes) S Jain, SR Patil, NK Swarnakar, AK Agrawal Molecular pharmaceutics 9 (9), 2626-2635, 2012 | 167 | 2012 |
| Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles NK Swarnakar, AK Jain, RP Singh, C Godugu, M Das, S Jain Biomaterials 32 (28), 6860-6874, 2011 | 162 | 2011 |
| Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B S Jain, PU Valvi, NK Swarnakar, K Thanki Molecular pharmaceutics 9 (9), 2542-2553, 2012 | 147 | 2012 |
| Role of antioxidants for the treatment of cardiovascular diseases: challenges and opportunities A K Jain, N K Mehra, N K Swarnakar Current pharmaceutical design 21 (30), 4441-4455, 2015 | 143 | 2015 |
| Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics AK Jain, M Das, NK Swarnakar, S Jain Critical Reviews™ in Therapeutic Drug Carrier Systems 28 (1), 2011 | 138 | 2011 |
| Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy V Jain, NK Swarnakar, PR Mishra, A Verma, A Kaul, AK Mishra, NK Jain Biomaterials 33 (29), 7206-7220, 2012 | 134 | 2012 |
| Enhanced oromucosal delivery of progesterone via hexosomes NK Swarnakar, V Jain, V Dubey, D Mishra, NK Jain Pharmaceutical research 24, 2223-2230, 2007 | 132 | 2007 |
| Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model AK Jain, NK Swarnakar, M Das, C Godugu, RP Singh, PR Rao, S Jain Molecular pharmaceutics 8 (4), 1140-1151, 2011 | 97 | 2011 |
| Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity NK Swarnakar, K Thanki, S Jain Pharmaceutical research 31, 1219-1238, 2014 | 81 | 2014 |
| Enhanced dermal delivery of acyclovir using solid lipid nanoparticles S Jain, MA Mistry, NK Swarnakar Drug delivery and translational research 1, 395-406, 2011 | 66 | 2011 |
| Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin-and Coenzyme Q10-liquid crystalline nanoparticles in comparison … NK Swarnakar, K Thanki, S Jain Nanomedicine: Nanotechnology, Biology and Medicine 10 (6), 1231-1241, 2014 | 55 | 2014 |
| Phytantriol based “stealth” lyotropic liquid crystalline nanoparticles for improved antitumor efficacy and reduced toxicity of docetaxel S Jain, N Bhankur, NK Swarnakar, K Thanki Pharmaceutical research 32, 3282-3292, 2015 | 42 | 2015 |
| Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles S Jain, R Mathur, M Das, NK Swarnakar, AK Mishra Nanomedicine 6 (10), 1733-1754, 2011 | 42 | 2011 |
| Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro–in vivo relationships NK Swarnakar, K Thanki, S Jain Molecular pharmaceutics 11 (5), 1435-1449, 2014 | 36 | 2014 |
| “Liquid crystalline nanoparticles”: rationally designed vehicle to improve stability and therapeutic efficacy of insulin following oral administration AK Agrawal, K Kumar, NK Swarnakar, V Kushwah, S Jain Molecular Pharmaceutics 14 (6), 1874-1882, 2017 | 32 | 2017 |
| Effect of co-administration of CoQ10-loaded nanoparticles on the efficacy and cardiotoxicity of doxorubicin-loaded nanoparticles NK Swarnakar, K Thanki, S Jain RSC advances 3 (34), 14671-14685, 2013 | 27 | 2013 |
| Improved oral bioavailability, therapeutic efficacy, and reduced toxicity of tamoxifen-loaded liquid crystalline nanoparticles S Jain, B Heeralal, R Swami, NK Swarnakar, V Kushwah AAPS PharmSciTech 19, 460-469, 2018 | 25 | 2018 |
| Lyotropic liquid crystalline nanoparticles of amphotericin B: Implication of phytantriol and glyceryl monooleate on bioavailability enhancement S Jain, P Yadav, R Swami, NK Swarnakar, V Kushwah, SS Katiyar AAPS PharmSciTech 19, 1699-1711, 2018 | 21 | 2018 |
Sanyog JainCentre for Pharmaceutical Nanotechnology, Dept of Pharmaceutics, NIPER在 niper.ac.in 的电子邮件经过验证
